We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

This study is currently recruiting participants.
Verified March 2016 by Dr Snehamay Chaudhuri, Nilratan Sircar Medical College
Sponsor:
ClinicalTrials.gov Identifier:
NCT01630954
First Posted: June 28, 2012
Last Update Posted: March 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr Snehamay Chaudhuri, Nilratan Sircar Medical College
  Purpose
Hydatidiform mole is a common complication of pregnancy with an incidence of 1in 400 pregnancies in India. Although this is a benign condition , it is having the malignant potential too. A repeat curettage after evacuation of hydatidiform mole was generally advocated till 1990s. A thorough curettage at the time of initial evacuation was not performed because of larger size of uterus and risk of perforation. Subsequently a number of studies assessed the usefulness of repeat curettage and found it was unnecessary and not cost effective . However all these studies are retrospective in design and conducted in developed countries where hydatidiform mole is diagnosed earlier because of wider use of ultrasonography. Thus there is a need to perform a well designed prospective study to compare the effectiveness of single evacuation with double evacuation in treatment of hydatidiform mole for prevention of Gestational Trophoblastic Neoplasia.This study compares the effectiveness of single evacuation versus double evacuation for treatment of hydatidiform mole for prevention of gestational trophoblastic neoplasia .

Condition Intervention Phase
Hydatidiform Mole Procedure: Suction and evacuation Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform

Resource links provided by NLM:


Further study details as provided by Dr Snehamay Chaudhuri, Nilratan Sircar Medical College:

Primary Outcome Measures:
  • Proportion of patents diagnosed as GTN following treatment in each group [ Time Frame: Six months following evacuation ]

Secondary Outcome Measures:
  • Maternal complications, [ Time Frame: Six months ]
  • Time interval of normalization of HCG [ Time Frame: Six months following evacuation ]
  • Duration of hospital stay [ Time Frame: Two weeks following admission ]

Estimated Enrollment: 120
Study Start Date: June 2012
Estimated Study Completion Date: June 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Single evacuation of mole, Procedure: Suction and evacuation
In single evacuation group women will be treated by suction evacuation and curettage is performed at the end of evacuation in one sitting. An ultrasound will be done later to examine completeness of evacuation. If there is significant amount of residual molar tissue or persistence of heavy bleeding a repeat curettage will be done . Women will be followed up with serum beta hcg 1 week after the evacuation and then weekly till the titer is negative. After three consecutive negative titre beat HCG estimation will be done at two weekly interval.
Other Name: Suction curettage
Active Comparator: Double evacuation of mole Procedure: Suction and evacuation
In double evacuation group , women will be treated by suction evacuation and a thorough curettage will be avoided. A second evacuation with thorough curettage will be performed after 5 - 7 days of first evacuation.
Other Name: Suction curettage

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ultrasound confirmed complete mole

Exclusion Criteria:

  • Partial mole
  • History of treatment for molar pregnancy like prior evacuation or chemotherapy
  • Women requiring hysterectomy for treatment of H Mole
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01630954


Contacts
Contact: Snehamay Chaudhuri, MD, DNB 091-33-23537900 snehamay_chaudhuri_dr@yahoo.com

Locations
India
Dr Snehamay Chaudhuri Recruiting
Kolkata, West Bengal, India, 700010
Contact: Snehamay Chaudhuri, MD, DNB    91-33-23537900    snehamay_chaudhuri_dr@yahoo.com   
Principal Investigator: Snehamay Chaudhuri, MD, DNB         
Sponsors and Collaborators
Nilratan Sircar Medical College
Investigators
Principal Investigator: Snehamay Chaudhuri, MD, DNB Associate Professor, Obstetrics and Gynecology, NRS Medical College , Kolkata,India
  More Information

Responsible Party: Dr Snehamay Chaudhuri, Associate Professor,Obstetrics and Gynecology, NRS Medical College, Nilratan Sircar Medical College
ClinicalTrials.gov Identifier: NCT01630954     History of Changes
Other Study ID Numbers: 4-Chaudhuri
First Submitted: June 24, 2012
First Posted: June 28, 2012
Last Update Posted: March 23, 2016
Last Verified: March 2016

Keywords provided by Dr Snehamay Chaudhuri, Nilratan Sircar Medical College:
Hydatidiform mole
Molar pregnancy
H Mole
GTN
GTD

Additional relevant MeSH terms:
Hydatidiform Mole
Gestational Trophoblastic Disease
Trophoblastic Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Pregnancy Complications, Neoplastic
Pregnancy Complications